• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) STYLE 410 LF RE-STERILIZABLE SIZER; SIZER, MAMMARY, BREAST IMPLANT VOLUME

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) STYLE 410 LF RE-STERILIZABLE SIZER; SIZER, MAMMARY, BREAST IMPLANT VOLUME Back to Search Results
Catalog Number N-SZLF390
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem Failure of Implant (1924)
Event Date 11/27/2015
Event Type  malfunction  
Manufacturer Narrative
The initial mdr decision on this complaint deemed this event not reportable.However, upon review, it was deemed a reportable malfunction and is being reported late.This deviation has been captured in investigation capa (b)(4).To date, no clarification has been received to confirm whether this device had been re-sterilized by the healthcare professional or was directly out of box.Device labeling addresses: "preliminary product examination: prior to use, examine the re-sterilizable sizer for any evidence of damage or particulate contamination.Do not use damaged or contaminated re-sterilizable sizers." reviewed device history record: review of dhr for work order (b)(4) did not identify any deviations, errors, omissions or non-conformances that may be associated with the reported device event.All saline breast implants were reviewed as part of the assembly operations and these tasks were performed according to applicable current procedures to ensure that assembly met the required specifications.In addition, dhr for shell runs number (b)(4) did not identify any deviations, errors, omissions or non-conformances that may be associated with the reported device event.All shells were reviewed as part of the shell fabrication operations and these tasks were performed according to applicable current procedures to ensure that fabrication met the required specifications.According to the information gathered during the dhr review, there is enough evidence to support that devices from work order (b)(4) were assembled in accordance with allergan medical procedures and specifications.
 
Event Description
Pharmacist reports: "fine particle plastic (diameter 1.5 cm) transparent (cellophane type) on sizers for anatomic implants (not for sizers for round implants).The sizers were therefore washed and still used to allow the installation of prosthesis, surgeons were notified of the defect and clean the sizers to avoid leaving particles 'inside the patient'." back-up device was not used as the physician "washed and still used" the device.
 
Manufacturer Narrative
Device is not available for analysis and therefore, the reported "particle plastic" present on the device cannot be confirmed by allergan.Review of device history record confirmed no identification of any deviations, errors, omissions or non-conformances that may be associated with the reported device event.According to the information gathered during the dhr review, there is enough evidence to support that devices from work order (b)(4) were assembled in accordance with allergan medical procedures and specifications.Mfr # 9617229-2015-00594 captures an additional device used on this patient during the same surgery with the same reported event.
 
Event Description
Per follow-up, physician reported, "the sizers have not been re-sterilized before use, the nurses simply removed the particles and cleaned the prosthesis.Devices have been kept as usual in our institution: ambient temperature, in their initial packaging (packaging allergan).The implants are never to be opened before surgery.Its only when the physician decides which implant will be implanted that they are taken out of the allergan boxes.I really don't think that the particles could provide from the environment they were kept, because we didn't came across similar case since this report." further clarification was received to confirm that the sizer had not been used before, had not been previously sterilized, and was removed directly from the allergan packaging.The particles were noticed when the sizer was removed from the packaging.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STYLE 410 LF RE-STERILIZABLE SIZER
Type of Device
SIZER, MAMMARY, BREAST IMPLANT VOLUME
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS  
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key5585561
MDR Text Key42942557
Report Number9617229-2015-00595
Device Sequence Number1
Product Code MRD
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K831566
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date 12/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/18/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2019
Device Catalogue NumberN-SZLF390
Device Lot Number2700060
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/28/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/31/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age48 YR
-
-